COMMUNITY CLINICAL ONCOLOGY PROGRAM

社区临床肿瘤学计划

• 批准号: 2894612
• 负责人: CHARLES L LOPRINZI
• 金额: $ 95.91万
• 依托单位: MAYO CLINIC ROCHESTER
• 依托单位国家: 美国
• 财政年份: 1983
• 资助国家: 美国
• 起止时间: 1983-09-15 至 2001-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/2894612
• 关键词: alternative medicine; analgesics; anorexia; behavioral /social science research tag; cachexia; cancer pain; chemoprevention; clinical research; clinical trials; community health services; drug addiction; health science research analysis /evaluation; human subject; human therapy evaluation; longitudinal human study; lymphedema; meeting /conference /symposium; neoplasm /cancer; neoplasm /cancer radiation therapy; neoplasm /cancer surgery; neoplasm /cancer therapy; nicotine; oncology; pathology

DESCRIPTION: (Applicant's narrative) The Mayo Clinic through the vehicle of the North Central Cancer Treatment Group (NCCTG) will serve as a primary research base for the following 14 CCOPs: Ann Arbor Regional CCOP, Carle Cancer Center CCOP, Cedar Rapids Oncology Project CCOP, the Duluth CCOP, the Iowa Oncology Research Association, the Merit Care Hospital CCOP, Geisinger CCOP, Missouri Valley Cancer Consortium CCOP, Ochsner CCOP, Illinois Oncology Research Association CCOP, the Arizona Minority CCOP, Scottsdale CCOP, Sioux Community Cancer Consortium CCOP, and the Toledo CCOP. We will also serve as research base for cancer control protocol activity of non-CCOP participants and for the multiple CCOP's outside of our group who contribute to intergroup cancer treatment and cancer control protocols which we lead. We will cooperate with our affiliated CCOPs in planning their program and in conducting appropriate continuing education and workshops. We will provide training and active support for their data managers and oncology nurses. We will coordinate their multi-disciplinary involvement in clinical cancer research protocols. This will include evolving and maintaining standard reporting procedures for surgery, pathology, and radiation therapy. We will hold regular meetings of the CCOPs for review of ongoing research, planning future research, and for related professional activities. We will continue the rigid quality control procedures which have provided so successful in the past, and upgrade these procedures as indicated. We will constantly monitor CCOP performance not only by timely review of patients, data sheets, pathology material, operative reports, and radiation therapy port films, but also by periodic randomly scheduled monitoring site visits. We will work with each CCOP participant to aid in their maturation as clinical investigators. We will assist them in developing new protocols for which they will share leadership, and we will work with them in preparing publications as well as presentations for national and regional meetings. We will make every effort to provide them with justifiable pride in their participation in the National Cancer Program. A high priority over this grant period will be the further expansion of our cancer control efforts into cancer prevention with incorporation of associated basic laboratory support.

描述：（申请人的叙述）梅奥诊所通过 中北部癌症治疗小组 (NCCTG) 将作为主要 以下 14 个 CCOP 的研究基地：Ann Arbor Regional CCOP、Carle 癌症中心 CCOP、锡达拉皮兹肿瘤学项目 CCOP、德卢斯 CCOP、 爱荷华州肿瘤学研究协会、Merit Care 医院 CCOP、Geisinger CCOP，密苏里河谷癌症联盟 CCOP，Ochsner CCOP，伊利诺伊州 肿瘤学研究协会 CCOP，亚利桑那州少数族裔 CCOP，斯科茨代尔 CCOP、苏族社区癌症联盟 CCOP 和托莱多 CCOP。 我们将 也作为非 CCOP 癌症控制方案活动的研究基地 参与者以及我们小组之外做出贡献的多个 CCOP 我们领导的团体间癌症治疗和癌症控制方案。 我们将与我们的附属 CCOP 合作规划他们的计划并 开展适当的继续教育和讲习班。 我们将提供 为其数据管理人员和肿瘤护士提供培训和积极支持。 我们 将协调他们在临床癌症方面的多学科参与 研究协议。 这将包括发展和维护标准 报告手术、病理学和放射治疗的程序。 我们将 定期召开 CCOP 会议，审查正在进行的研究、规划 未来的研究以及相关的专业活动。 我们将继续 严格的质量控制程序在 过去，并按照指示升级这些程序。 我们将不断 不仅通过及时审查患者、数据表、 病理材料、手术报告和放射治疗端口胶片，但是 还可以定期随机安排监测现场访问。 我们将工作 与每位 CCOP 参与者一起帮助他们作为临床专家走向成熟 调查人员。 我们将协助他们开发新协议 他们将分享领导力，我们将与他们合作准备 出版物以及在国家和区域会议上的演讲。 我们将尽一切努力为他们提供合理的自豪感 参与国家癌症计划。 对此高度优先 资助期将进一步扩大我们的癌症控制工作 纳入相关基础实验室以预防癌症 支持。